| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Esperion Therapeutics, Inc. | Director | Stock Option (right to buy) | 88,000 | $105,300 | $1.62 | 29 May 2025 | Direct |
| MARINUS PHARMACEUTICALS INC | Director | Common Stock | 6,442 | $57,527 | $8.93 | 04 Feb 2022 | Direct |
| MARINUS PHARMACEUTICALS INC | Director | Stock Option (Right to Buy) | 12,375 | 04 Feb 2022 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| ESPR | Esperion Therapeutics, Inc. | 29 May 2025 | 1 | $0 | 4 | Director | 02 Jun 2025, 16:07 |
| ESPR | Esperion Therapeutics, Inc. | 23 May 2024 | 1 | $0 | 4 | Director | 24 May 2024, 16:13 |
| ESPR | Esperion Therapeutics, Inc. | 15 Jun 2023 | 2 | $0 | 4 | Director | 16 Jun 2023, 16:07 |
| ESPR | Esperion Therapeutics, Inc. | 26 May 2022 | 1 | $0 | 4 | Director | 27 May 2022, 16:18 |
| /report/000110465922012796-vitullo-nicole-2022-02-04 | MARINUS PHARMACEUTICALS INC | 04 Feb 2022 | 2 | $0 | 4 | Director | 07 Feb 2022, 15:14 |
| ESPR | Esperion Therapeutics, Inc. | 27 May 2021 | 1 | $0 | 4 | Director | 28 May 2021, 16:17 |